Updated:
Montauk Ventures
Montauk Ventures is a generalist investment firm established in 2023. It focuses on hypergrowth-stage companies in the biotech and life science sectors.
Montauk Ventures
Montauk Ventures is a generalist investment firm established in 2023. It focuses on hypergrowth-stage companies in the biotech and life science sectors.
General information
Firm type
Venture Capital
Year founded
2021
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Frequently asked questions
What investment stage does Montauk Ventures target?
Montauk Ventures focuses on growth-stage companies that have achieved repeatable revenue. The firm does not invest in seed, pre-revenue, or concept-stage ventures. Its capital is used to scale operations, expand into new markets, and build out management teams at companies that have already demonstrated product-market fit. Buyouts of mature, cash-flowing businesses are also not part of the mandate.
Which sectors does Montauk Ventures explicitly avoid?
Montauk's growth-equity mandate not covering seed or buyout stages implicitly excludes capital-intensive industries that require venture-style R&D timelines or buyout-style leverage: biotechnology, pharmaceuticals, heavy manufacturing, and real estate development. The firm's public communications point toward asset-light business models rather than hard-asset plays.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: